763 related articles for article (PubMed ID: 22959595)
21. Exosomes as nucleic acid nanocarriers.
van den Boorn JG; Dassler J; Coch C; Schlee M; Hartmann G
Adv Drug Deliv Rev; 2013 Mar; 65(3):331-5. PubMed ID: 22750807
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers.
Jo W; Jeong D; Kim J; Cho S; Jang SC; Han C; Kang JY; Gho YS; Park J
Lab Chip; 2014 Apr; 14(7):1261-9. PubMed ID: 24493004
[TBL] [Abstract][Full Text] [Related]
23. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells.
Cho JA; Park H; Lim EH; Lee KW
Int J Oncol; 2012 Jan; 40(1):130-8. PubMed ID: 21904773
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.
Motavaf M; Pakravan K; Babashah S; Malekvandfard F; Masoumi M; Sadeghizadeh M
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):74-9. PubMed ID: 27453276
[TBL] [Abstract][Full Text] [Related]
25. From structures to functions: insights into exosomes as promising drug delivery vehicles.
Ren J; He W; Zheng L; Duan H
Biomater Sci; 2016 May; 4(6):910-21. PubMed ID: 26977477
[TBL] [Abstract][Full Text] [Related]
26. Large-scale generation of cell-derived nanovesicles.
Jo W; Kim J; Yoon J; Jeong D; Cho S; Jeong H; Yoon YJ; Kim SC; Gho YS; Park J
Nanoscale; 2014 Oct; 6(20):12056-64. PubMed ID: 25189198
[TBL] [Abstract][Full Text] [Related]
27. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
[TBL] [Abstract][Full Text] [Related]
28. Radiation increases the cellular uptake of exosomes through CD29/CD81 complex formation.
Hazawa M; Tomiyama K; Saotome-Nakamura A; Obara C; Yasuda T; Gotoh T; Tanaka I; Yakumaru H; Ishihara H; Tajima K
Biochem Biophys Res Commun; 2014 Apr; 446(4):1165-71. PubMed ID: 24667602
[TBL] [Abstract][Full Text] [Related]
29. Exosomes as Tools to Suppress Primary Brain Tumor.
Katakowski M; Chopp M
Cell Mol Neurobiol; 2016 Apr; 36(3):343-52. PubMed ID: 26983831
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cell therapy and delivery systems in nonhealing wounds.
Brower J; Blumberg S; Carroll E; Pastar I; Brem H; Chen W
Adv Skin Wound Care; 2011 Nov; 24(11):524-32; quiz 533-4. PubMed ID: 22015751
[TBL] [Abstract][Full Text] [Related]
31. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts.
Cho JA; Park H; Lim EH; Kim KH; Choi JS; Lee JH; Shin JW; Lee KW
Gynecol Oncol; 2011 Nov; 123(2):379-86. PubMed ID: 21903249
[TBL] [Abstract][Full Text] [Related]
32. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.
Lakhal S; Wood MJ
Bioessays; 2011 Oct; 33(10):737-41. PubMed ID: 21932222
[TBL] [Abstract][Full Text] [Related]
33. Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.
Kibria G; Ramos EK; Wan Y; Gius DR; Liu H
Mol Pharm; 2018 Sep; 15(9):3625-3633. PubMed ID: 29771531
[TBL] [Abstract][Full Text] [Related]
34. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
35. Exosomes: small vesicles participating in intercellular communication.
Ludwig AK; Giebel B
Int J Biochem Cell Biol; 2012 Jan; 44(1):11-5. PubMed ID: 22024155
[TBL] [Abstract][Full Text] [Related]
36. Bibliometric and visualized analysis of the applications of exosomes based drug delivery.
Wei B; Huang H; Cao Q; Song X; Zhang Z
Biomed Pharmacother; 2024 Jul; 176():116803. PubMed ID: 38788602
[TBL] [Abstract][Full Text] [Related]
37. [Exosomes Derived from Mesenchymal Stem Cells--the Future Ideal Vector of Biological Therapy].
Zhang J; Shi JS; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1179-83. PubMed ID: 26314469
[TBL] [Abstract][Full Text] [Related]
38. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
[TBL] [Abstract][Full Text] [Related]
39. Effective internalization of U251-MG-secreted exosomes into cancer cells and characterization of their lipid components.
Toda Y; Takata K; Nakagawa Y; Kawakami H; Fujioka S; Kobayashi K; Hattori Y; Kitamura Y; Akaji K; Ashihara E
Biochem Biophys Res Commun; 2015 Jan; 456(3):768-73. PubMed ID: 25498500
[TBL] [Abstract][Full Text] [Related]
40. [Glioma treatment strategies using mesenchymal stem cells].
Namba H
Brain Nerve; 2010 Oct; 62(10):1075-82. PubMed ID: 20940507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
